Moving towards a process to manufacture [11C]UCB-J for preclinical and clinical studies
Impact of injected [177Lu]Lu-rhPSMA10.1 mass and PSMA expression on tumour absorbed dose
Neue Ansätze zur Therapie neuroendokriner Tumoren
